P&G Buys Thorne for $3.8B, Boosting Health & Wellness

Procter & Gamble (P&G) is set to acquire supplements manufacturer Thorne for $3.8 billion, a move confirmed by CEO Shailesh Jejurikar to CNBC on Tuesday. This strategic acquisition aims to significantly expand P&G’s footprint in the rapidly growing health and wellness market, leading to an increase of nearly 2% in P&G’s shares on Wall Street.

Jejurikar articulated that the acquisition price is justified by Thorne’s robust growth trajectory, aligning with established industry valuation benchmarks. The integration of Thorne will notably enhance P&G’s position within the vitamins, minerals, and supplements (VMS) sector, addressing the rising consumer demand for preventive health and self-care solutions.

Strategic Market Expansion

P&G already holds a presence in the supplements market through brands such as New Chapter, Metamucil, and Align Probiotic. The addition of Thorne is expected to further diversify its portfolio and strengthen its competitive edge in this evolving segment.

The increasing consumer interest in healthier lifestyles and the emergence of weight-loss medications are key factors driving demand for health and wellness products. Rachel Wolff, a senior analyst at eMarketer, noted that this acquisition reflects strong current consumer demand and could help P&G offset weaker performances in other product categories.

Thorne’s Financial Trajectory

Founded in 1984, Thorne was privatized in 2023 by L Catterton, an LVMH-backed private equity firm, in a $680 million transaction. P&G’s $3.8 billion acquisition represents a substantial return for L Catterton in approximately three years.

Thorne, which was previously publicly listed, projected annual sales of about $290 million for 2023. CNBC reported an expected revenue of approximately $650 million for the current year. Consumer health company Haleon had also expressed interest in acquiring Thorne.

Broader Industry Trends

P&G’s move to acquire Thorne aligns with a broader industry trend where global consumer companies are actively vying for increased market share in the wellness sector. Other major players, like Unilever, have also made strategic acquisitions, including the nutritional supplements brand Grüns.

Conversely, Nestlé is currently reevaluating its VMS portfolio due to concerns regarding growth and margins within the segment. P&G’s acquisition follows its own forecast of slower annual sales growth, despite strong performance in its beauty and wellness division, with shares trading at $147.29 apiece on the NYSE, up approximately 1.63% at 1:40 pm EST.